Shilpa Medicare submits new drug application for kidney disease, stock hits all-time high

From Google: 2024-09-04 05:24:34

Shilpa Medicare has submitted a new drug application to the USFDA for a treatment for chronic kidney disease. This news has resulted in the company’s stock hitting an all-time high.



Read more at Google: Shilpa Medicare submits new drug application to USFDA for kidney disease treatment, stock hits all-time high – CNBCTV18